BiotechTube
Animated Dynamics

Animated Dynamics

Nashville, United States· Est.
anidyn.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $6.4M

Overview

Animated Dynamics is a private, pre-revenue diagnostics company developing a novel phenomic testing platform called Motility Contrast Tomography (MCT). The company's flagship product, Onco4D, aims to guide chemotherapy selection in breast cancer by measuring dynamic cellular responses in tumor biopsies, with recent clinical trial data presented at ASCO showing a 97% negative predictive value. Founded in 2014 and backed by Caravel Ventures, the company is led by a team with private equity, operational, and clinical oncology expertise, positioning it to enter the personalized cancer diagnostics market.

Oncology

Technology Platform

Motility Contrast Tomography (MCT), an advanced digital holography platform that measures nano-scale kinetic activity and dynamic cellular responses in living tissue biopsies to create a phenomic signature for predicting treatment response.

Funding History

3
Total raised:$6.4M
Seed$1.7M
Seed$4.2M
Grant$500K

Opportunities

The Onco4D test addresses a significant unmet need in breast cancer by potentially sparing non-responders from ineffective and toxic chemotherapy, which could lead to rapid clinical adoption and favorable reimbursement.
The underlying MCT platform technology is broadly applicable to other solid tumors and drug classes, offering a substantial pipeline expansion opportunity beyond the initial breast cancer indication.

Risk Factors

The company faces clinical validation risk, as its novel technology requires confirmation in larger trials, and commercialization risk, including challenges in changing clinical practice and securing payer reimbursement.
It also operates in a highly competitive diagnostics landscape against established genomic tests and is dependent on its private equity backer for continued funding.

Competitive Landscape

Animated Dynamics competes in the precision oncology diagnostics market against established genomic profiling tests like Exact Sciences' Oncotype DX and Agendia's MammaPrint, which predict recurrence risk but not direct chemotherapy response. It also faces competition from other functional diagnostic approaches, such as organoid-based drug sensitivity testing. Its key differentiator is the real-time, label-free measurement of subcellular dynamics in intact tissue.

More companies in Diagnostics & Precision Medicine →More companies in United States →